Biomarker‐guided trials are ongoing, for example, studies testing anti‐inflammatory therapies in patients with elevated CRP (such as CANTOS and COLCOT in coronary disease), approaches that could be adapted for stroke. The gene discussed is CRP; the disease is Stroke.